Centro Regional Integrado de Oncologia ( Site 0160)

Fortaleza, Ceará 60336-232

0 studies enrolling now · 2 studies all time

What they study most

Head and Neck Neoplasms, Non-small Cell Lung Cancer

Studies at this site

• Study of Pembrolizumab Given Prior to Surgery and in Combination With Radiotherapy Given Post-surgery for Advanced Head and Neck Squamous Cell Carcinoma (MK-3475-689) — Running, not enrolling
• Efficacy and Safety of Pembrolizumab (MK-3475) With Platinum Doublet Chemotherapy as Neoadjuvant/Adjuvant Therapy for Participants With Resectable Stage II, IIIA, and Resectable IIIB (T3-4N2) Non-small Cell Lung Cancer (MK-3475-671/KEYNOTE-671) — Running, not enrolling